CB2 Insights Licenses Electronic Data Capture Software to MyAccess Clinics for Use In the UK
19 sept. 2019 07h28 HE
|
CB2 Insights
Company strengthens market presence in United Kingdom with licensing of Electronic Data Capture Technology in partnership with UK-based MyAccess ClinicsMyAccess Clinics to use CB2’s software within...
EXMCeuticals Inc. provides Corporate Update
10 sept. 2019 09h00 HE
|
EXMceuticals Inc.
VANCOUVER, British Columbia, Sept. 10, 2019 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a cultivator and producer of cannabis extractions and refined...
CB2 Insights Announces Appointment of Medical Director in Colombia and Enters Market with Cannabis Research Focus
03 sept. 2019 08h20 HE
|
CB2 Insights
Company recruits prominent Colombian naturopathic and integrative medicine physician Dr. Paola Cubillos, MD, ND to lead medical cannabis research programs to advance emerging marketRapid growth in...
CB2 Insights to Host Q2 2019 Earnings Call on August 28, 2019
20 août 2019 16h35 HE
|
CB2 Insights
TORONTO, Aug. 20, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE:CBII; OTCQB:CBIIF), a leading data-driven company focused on bringing real-world evidence driven from the...
EXMceuticals Inc. appoints cannabis industry leader Tripp Keber as Strategic Advisor to the Board
20 août 2019 09h00 HE
|
EXMceuticals Inc.
VANCOUVER, British Columbia, Aug. 20, 2019 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a cultivator and producer of high-grade cannabis extracted...
CB2 Insights Announces New Appointment to Board of Directors with Medical Cannabis and Capital Markets Executive
01 août 2019 08h00 HE
|
CB2 Insights
TORONTO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...
CB2 Insights Adds Former Johnson & Johnson Executive as Director
31 juil. 2019 08h00 HE
|
CB2 Insights
TORONTO, July 31, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...
CB2 Insights Selected by Drug Science as Research Technology Platform for the UK’s Largest Medical Cannabis Pilot
18 juil. 2019 07h11 HE
|
CB2 Insights
NEWS HIGHLIGHTS CB2 Insights has been selected as exclusive research technology platform for the UK’s largest medical cannabis Pilot - Project TWENTY21Project TWENTY21 aims to enroll 20,000 patients...
CB2 Insights Selected by Drug Science as Research Technology Platform for the UK’s Largest Medical Cannabis Pilot
18 juil. 2019 07h11 HE
|
CB2 Insights
NEWS HIGHLIGHTS CB2 Insights has been selected as exclusive research technology platform for the UK’s largest medical cannabis Pilot - Project TWENTY21Project TWENTY21 aims to enroll 20,000 patients...
CB2 Insights and Premier Health Group Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluations
09 juil. 2019 07h30 HE
|
CB2 Insights
TORONTO, July 09, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIT) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...